ADME-Tox supplier Nimbus changes name to Sovicell

Leipzig, Germany – ADME-Tox product developer Nimbus Biotechnologie has changed its name to Sovicell, effective immediately. The company says the change reflects its move to become a full range, international supplier of ADME-Tox products and services for pre-clinical research.

Founded in 1994, the company produces bead-based in vitro testing procedures for reliably measuring a drug candidate’s membrane permeability and protein binding. The testing can enable early and accurate prediction of the efficacy and safety of drug candidates and prevent costly failures in clinical trials.